Article

How Huntingtin Protein Kills Neurons

French researchers have discovered how the deadly changes that lead to Huntington's disease are caused.

French researchers from the Institut Curie, Orsay—who published their study results in the August 12 issue of Neuron—have discovered how the deadly changes that lead to Huntington’s disease are caused by a defective huntingtin protein. Specifically, they have revealed that the protein likely disrupts neurogenesis and thus decreases neural progenitor cells.

The study is the first to decipher the role played by the huntingtin protein in neuronal development, which is likely related to the deadly effects of Huntington’s disease, despite knowledge that it is implicated in numerous cellular functions, like signaling, transport, binding, and apoptosis.

"For a while it has been known that huntingtin was involved in vesicle transport; they took it a step further to ask what else might be impacted by it," Scott Zeitlin, neuroscientist, University of Virginia School of Medicine, told The Scientist.

When Humbert’s team silenced huntingtin in dividing cells, the cells couldn’t accurately orient their spindles and thus progenitor cells became misaligned and produced more neurons, not more neuronal progenitor cells. Without these progenitor cells, neurons are unable to be produced in the brain when older neurons dies.

"Some people have, for a while, hypothesized that there could be a developmental aspect for Huntington's disease, this at least gives you a window of where to look to see where it may be occurring," said Zeitlin. "Most people think of this disease as a late-onset disorder, but there are always things that could be laid down early in development that could predispose these neurons to problems later."

Learn more about the study findings here, or check out the article in Neuron.

More Huntington’s Disease in the News:

  • In Normal Aging Process, Proteins Linked with Alzheimer's Clump
  • UCLA's Ben Howland to Help Raise Funds for Huntington's Disease Research
  • Huntington’s Disease and Breast Cancer in Gene Checking Clampdown Announced
  • Cause of Damage from Huntington’s Disease ‘Discovered’
  • New Drugs Eyed for Huntington’s Disease
Related Videos
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
Stephanie Nahas, MD, MSEd | Credit: Jefferson Health
John Harsh, PhD: Exploring Once-Nightly Sodium Oxybate Therapy for Narcolepsy
John Harsh, PhD
© 2024 MJH Life Sciences

All rights reserved.